Medleaf Sydney operates under the Australian federal medical cannabis framework administered by the Therapeutic Goods Administration (TGA). The TGA oversees the Authorised Prescriber (AP) pathway and the Special Access Scheme (SAS), both of which allow registered patients to access approved medicinal cannabis products legally. Since the TGA streamlined approvals in 2020, patient numbers across Australia have grown exponentially, and Sydney has become one of the most active medical cannabis markets in the Asia-Pacific region. Medleaf Sydney supports patients through the prescription process, product selection and ongoing consultations, working within the strict TGA compliance framework that governs all Australian medical cannabis operations.
Parramatta in Sydney is a key catchment area for medical cannabis patients seeking convenient access to approved dispensaries and clinics. The local patient population includes chronic pain sufferers, mental health patients, cancer patients in palliative care, and patients with neurological conditions who have found conventional treatments insufficient. Medleaf Sydney serves this diverse patient base from its Parramatta location, providing a discreet, professional environment where patients can discuss their needs with trained clinical staff and receive guidance on TGA-approved products.
Explore all locations in Sydney
← Back to Sydney